These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 16490577)

  • 1. Statin-related adverse events: a meta-analysis.
    Silva MA; Swanson AC; Gandhi PJ; Tataronis GR
    Clin Ther; 2006 Jan; 28(1):26-35. PubMed ID: 16490577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy.
    Silva M; Matthews ML; Jarvis C; Nolan NM; Belliveau P; Malloy M; Gandhi P
    Clin Ther; 2007 Feb; 29(2):253-60. PubMed ID: 17472818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of benefits and risks of rosuvastatin versus atorvastatin from a meta-analysis of head-to-head randomized controlled trials.
    Wlodarczyk J; Sullivan D; Smith M
    Am J Cardiol; 2008 Dec; 102(12):1654-62. PubMed ID: 19064019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risks associated with statin therapy: a systematic overview of randomized clinical trials.
    Kashani A; Phillips CO; Foody JM; Wang Y; Mangalmurti S; Ko DT; Krumholz HM
    Circulation; 2006 Dec; 114(25):2788-97. PubMed ID: 17159064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients.
    Nichols GA; Koro CE
    Clin Ther; 2007 Aug; 29(8):1761-70. PubMed ID: 17919557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients.
    Mills EJ; Rachlis B; Wu P; Devereaux PJ; Arora P; Perri D
    J Am Coll Cardiol; 2008 Nov; 52(22):1769-81. PubMed ID: 19022156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosuvastatin 5 and 10 mg/d: a pilot study of the effects in hypercholesterolemic adults unable to tolerate other statins and reach LDL cholesterol goals with nonstatin lipid-lowering therapies.
    Glueck CJ; Aregawi D; Agloria M; Khalil Q; Winiarska M; Munjal J; Gogineni S; Wang P
    Clin Ther; 2006 Jun; 28(6):933-42. PubMed ID: 16860175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are statins created equal? Evidence from randomized trials of pravastatin, simvastatin, and atorvastatin for cardiovascular disease prevention.
    Zhou Z; Rahme E; Pilote L
    Am Heart J; 2006 Feb; 151(2):273-81. PubMed ID: 16442888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of side-effect profile of combination ezetimibe and statin therapy in randomized clinical trials.
    Kashani A; Sallam T; Bheemreddy S; Mann DL; Wang Y; Foody JM
    Am J Cardiol; 2008 Jun; 101(11):1606-13. PubMed ID: 18489938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of rosuvastatin: update on 16,876 rosuvastatin-treated patients in a multinational clinical trial program.
    Shepherd J; Vidt DG; Miller E; Harris S; Blasetto J
    Cardiology; 2007; 107(4):433-43. PubMed ID: 17363845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of a data mining signal for amyotrophic lateral sclerosis and statins detected in FDA's spontaneous adverse event reporting system.
    Colman E; Szarfman A; Wyeth J; Mosholder A; Jillapalli D; Levine J; Avigan M
    Pharmacoepidemiol Drug Saf; 2008 Nov; 17(11):1068-76. PubMed ID: 18821724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse events associated with individual statin treatments for cardiovascular disease: an indirect comparison meta-analysis.
    Alberton M; Wu P; Druyts E; Briel M; Mills EJ
    QJM; 2012 Feb; 105(2):145-57. PubMed ID: 21920996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia.
    Bays HE; Davidson M; Jones MR; Abby SL
    Am J Cardiol; 2006 Apr; 97(8):1198-205. PubMed ID: 16616026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The statin studies: from targeting hypercholesterolaemia to targeting the high-risk patient.
    Ong HT
    QJM; 2005 Aug; 98(8):599-614. PubMed ID: 16006501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The risk for significant creatine kinase elevation with statins.
    Stolcpart RS; Olson KL; Delate T; Rasmussen J; Rehring TF; Merenich JA
    Am J Cardiovasc Drugs; 2010; 10(3):187-92. PubMed ID: 20524720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should high creatine kinase discourage the initiation or continuance of statins for the treatment of hypercholesterolemia?
    Glueck CJ; Rawal B; Khan NA; Yeramaneni S; Goldenberg N; Wang P
    Metabolism; 2009 Feb; 58(2):233-8. PubMed ID: 19154957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhabdomyolysis with HMG-CoA reductase inhibitors and gemfibrozil combination therapy.
    Chang JT; Staffa JA; Parks M; Green L
    Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):417-26. PubMed ID: 15269925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin therapy for the prevention of atrial fibrillation: a meta-analysis of randomized controlled trials.
    Wang Z; Zhang Y; Gao M; Wang J; Wang Q; Wang X; Su L; Hou Y
    Pharmacotherapy; 2011 Nov; 31(11):1051-62. PubMed ID: 22026393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Striated muscle safety of ezetimibe/simvastatin (Vytorin).
    Davidson MH; Maccubbin D; Stepanavage M; Strony J; Musliner T
    Am J Cardiol; 2006 Jan; 97(2):223-8. PubMed ID: 16442367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.